Neuronetics is trading 5.32% higher at $2.27 on October 5, but no specific catalyst has been identified.
- Shares are up from the October 2 close of $2.16.
- No fresh company-specific announcement was found; the investor-relations news page shows no October 5 release.
- The Nasdaq is up 0.69% and the S&P 500 0.44%, while the Dow is slightly lower. Those index gains are below the threshold for attributing the move to broad-market sentiment.